Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread

Journal of Clinical Oncology

Volumn 22, Issue 11, 2004, Pages 2192-2201

  Friedberg, Joseph S ^a   Mick, Rosemarie ^a   Stevenson, James P ^a   Zhu, Timothy ^a   Busch, Theresa M ^a   Shin, Daniel ^a   Smith, Debbie ^a   Culligan, Melissa ^a   Dimofte, Andreea ^a   Glatstein, Eli ^a   Hahn, Stephen M ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT;

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; HUMAN; HUMAN TISSUE; ILLUMINATION; INTRAOPERATIVE PERIOD; LUNG NON SMALL CELL CANCER; PHOTODYNAMIC THERAPY; PLEURA CAVITY; PRIORITY JOURNAL; ADULT; AGED; DISEASE FREE SURVIVAL; FEMALE; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PHOTOCHEMOTHERAPY; PLEURA TUMOR; SURVIVAL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 2942635845     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.07.097     Document Type: Article

References (26)

1. Jemal A, Murray T, Samuels A: Cancer Statistics, 2003. CA Cancer J Clin 53:5-26, 2003
2. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1997. CA Cancer J Clin 47: 5-27, 1997
3. Werner-Wasik M, Scott C, Cox JD, et al: Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival. Int J Radiat Oncol Biol Phys 48: 1475-1482, 2000
4. Leong SS, Rocha Lima CM, Sherman CA, et al: The 1997 International Staging System for non-small cell lung cancer: Have all the issues been addressed? Chest 115:242-248, 1999
5. Sugiura S, Ando Y, Minami H, et al: Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 3:47-50, 1997
6. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 111:1710-1717, 1997
7. Martini N, Bains MS, Beattie EJ Jr: Indications for pleurectomy in malignant effusion. Cancer 35:734-738, 1975
8. Reyes L, Parvez Z, Regal AM, et al: Neoadjuvant chemotherapy and operations in the treatment of lung cancer with pleural effusion. J Thorac Cardiovasc Surg 101:946-947, 1991
9. Mott FE, Sharma N, Ashley P: Malignant pleural effusion in non-small cell lung cancer-time for a stage revision? Chest 119:317-318, 2001
10. Mattson K, Holsti LR, Tammilehto L, et al: Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation. Int J Radiat Oncol Biol Phys 24:643-650, 1992
11. Yokoi K, Matsuguma H, Anraku M: Extrapleural pneumonectomy for lung cancer with carcinomatous pleuritis. J Thorac Cardiovasc Surg 123:184-185, 2002
12. Ichinose Y, Tsuchiya R, Koike T, et al: Prognosis of resected non-small cell lung cancer patients with carcinomatous pleuritis of minimal disease. Lung Cancer 32:55-60, 2001
13. Naruke T, Tsuchiya R, Kondo H, et al: Implications of staging in lung cancer. Chest 112:242S-248S, 1997
14. Ichinose Y, Yano T, Asoh H, et al: Intraoperative intrapleural hypotonic cisplatin treatment for carcinomatous pleuritis. J Surg Oncol 66:196-200, 1997
15. Yokoi K, Miyazawa N: Pleuropneumonectomy and postoperative adjuvant chemotherapy for carcinomatous pleuritis in primary lung cancer: A case report of long-term survival. Eur J Cardiothorac Surg 10:141-143, 1996
16. Shimizu J, Oda M, Morita K, et al: Comparison of pleuropneumonectomy and limited surgery for lung cancer with pleural dissemination. J Surg Oncol 61:1-6, 1996
17. Dougherty TJ, Corner CJ, Henderson BW, et al: Photodynamic therapy. J Natl Cancer Inst 90:889-905, 1998
18. Gomer C, Dougherty T: Determination of [3H]- and [14C] hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 39:146-151, 1979
19. Hahn S, Glatstein E: The Emergence of Photodynamic Therapy as a Major Modality in Cancer Treatment. Rev Contemp Pharmocother 10:69-74, 1999
20. Pass HI, DeLaney TF, Tochner Z, et al: Intrapleural photodynamic therapy: Results of a phase I trial. Ann Surg Oncol 1:28-37, 1994
21. Temeck BK, Pass HI: Esophagopleural fistula: A complication of photodynamic therapy. South Med J 88:271-274, 1995
22. Pass HI, DeLaney T, Tochner Z, et al: Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg 50:687-688, 1990
23. Bellnier DA, Greco WR, Parsons JC, et al: An Assay for the Quantiation of Photofrin in Tissues and Fluids. Photochem Photobiol 66: 237-244, 1997
24. Komaki R, Seiferheld W, Curran W, et al: Sequential vs. concurrent chemotherapy and radiation therapy for inoperable non-small cell lung cancer (NSCLC): Analysis of failures in a phase III study (RTOG 9410). Int J Radiat Oncol Biol Phys 48:113, 2000 (abstr5)
25. Furuse K, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692-2699, 1999
26. Dillman RO, Herndon J, Seagren SL, et al: Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial [see comments]. J Natl Cancer Inst 88:1210-1215, 1996